The shareholders of CAM Bioceramics have sold a majority stake to SHS Capital, a German investor specialising in healthcare, and ING Corporate Investments and will remain involved as minority shareholders.

Bioceramics, based in Leiden, the Netherlands, is a leading global producer of innovative calcium phosphate solutions for Medtech and LifeScience applications.

Click here for the press release.